ProShares UltraPro Nasdaq Biotechnology (UBIO)

Add to Watchlists
Create an Alert
26.68 -2.94  -9.93% NASDAQ Mar 22, 20:00 Delayed 2m USD
View Full Chart
UBIO Price Chart
View All UBIO News

UBIO News

UBIO Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -8.35% -8.58% -- --
3M 59.28% 59.46% -- --
6M -34.51% -34.71% -- --
YTD 33.40% 32.75% -- --
1Y -19.90% -19.96% -- --
3Y 2.97% 2.82% -- --
5Y -- -- -- --
10Y -- -- -- --
15Y -- -- -- --
20Y -- -- -- --
As of March 22, 2019. Returns for periods of 1 year and above are annualized.

UBIO Asset Allocation

Type % Net % Long % Short
Cash -200.1% 17.27% 217.4%
Stock 91.96% 91.96% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 208.1% 208.1% 0.00%
As of Feb. 28, 2019
View More Holdings

UBIO Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Nasdaq Biotechnology Index Swap Ubs Ag 73.86% -- --
-- Nasdaq Biotechnology Index Swap Societe Generale 47.00% -- --
-- Nasdaq Biotechnology Index Swap Bank Of America Na 46.46% -- --
-- Nasdaq Biotechnology Index Swap Goldman Sachs International 40.83% -- --
-- Nasdaq Biotechnology Index Swap Deutsche Bank Ag 9.23% -- --
BIIB Biogen Inc 6.42% 216.71 -4.48%
CELG Celgene Corp 6.04% 88.15 -1.65%
AMGN Amgen Inc 5.96% 186.70 -2.70%
GILD Gilead Sciences Inc 5.91% 63.77 -1.77%
ILMN Illumina Inc 4.78% 308.79 -3.26%
As of Feb. 28, 2019
Advertisement

UBIO Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading--Leveraged Equity
Prospectus Objective Specialty - Technology
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD
300.0%

UBIO Manager Info

Name Tenure
Michael Neches 3.61 yrs
Tarak Davé 0.76 yrs

UBIO Net Fund Flows

1M -4.598M
3M -4.020M
6M 3.526M
YTD -6.030M
1Y -7.965M
3Y -22.94M
5Y --
10Y --
As of Feb. 28, 2019

UBIO Risk Info

Beta (5Y) 4.499
Max Drawdown (All) 85.48%
Historical Sharpe (10Y) --
Historical Sortino (All) -0.0305
30-Day Rolling Volatility 65.23%
Daily Value at Risk (VaR) 1% (All) 12.12%
Monthly Value at Risk (VaR) 1% (All) 47.43%

UBIO Comparables

Edit

UBIO Attributes

Key Dates
Inception Date 6/22/2015
Termination Date
Last Annual Report Date 5/31/2018
Last Prospectus Date 6/12/2018
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

UBIO Excel Add-In Codes

  • Name: =YCI("UBIO","name")
  • Broad Asset Class: =YCI("UBIO", "broad_asset_class")
  • Broad Category: =YCI("UBIO", "broad_category_group")
  • Prospectus Objective: =YCI("UBIO", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.